BrosMed Attends the 13th China Venture Capital & Private Equity Semi-Annual Forum, 2013
Release time:
2013-07-15
July 12, 2013, BrosMed attended the 13th China Venture Capital & Private Equity Semi-Annual Forum, 2013. Benny Lee, the chairman of BrosMed, presented company’s medium-term strategy and equity trading plan. Couple of VCs joined the discussions for more specific questions and showed their interests during the meeting and follow up after meeting.
July 12, 2013, BrosMed attended the 13th China Venture Capital & Private Equity Semi-Annual Forum, 2013. Benny Lee, the chairman of BrosMed, presented company’s medium-term strategy and equity trading plan. Couple of VCs joined the discussions for more specific questions and showed their interests during the meeting and follow up after meeting. For more information regarding the host please visit http://www.zero2ipo.com.hk/cvcf/2013/2013fs/default.asp
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
